Jasper Therapeutics, Inc. (JSPR) has 20 known insider and institutional holders on record. The largest holder is Qiming U.S. Healthcare Fund II, L.P. with 8,519,648 shares. Other notable holders include ROCHE HOLDING LTD and HOFFEN HOWARD I.
Over the last 12 months, insiders have made 19 transactions in JSPR stock — 19 buys (valued at $5.23M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
JSPR Insider Ownership
Top Holder
Qiming U.S. Healthcare Fund II, L.P.
8,519,648 shares
Buys (12 mo)
19
$5.23M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Qiming U.s. Healthcare Fund Ii, L.p. |
10 Percent Owner |
8,519,648 |
2023-04-11 |
|
| 2 |
Roche Holding Ltd |
Director |
4,549,606 |
2023-01-26 |
|
| 3 |
Hoffen Howard I |
10 Percent Owner |
2,500,000 |
2020-01-07 |
|
| 4 |
Venkataraman Balaji |
10 Percent Owner, Officer: Chief Executive Officer |
2,500,000 |
2020-01-07 |
|
| 5 |
Clifford Kenneth F |
10 Percent Owner, Officer: Chief Financial Officer |
2,500,000 |
2020-01-07 |
|
| 6 |
Amplitude Healthcare Holdings Llc |
10 Percent Owner |
2,500,000 |
2020-01-07 |
|
| 7 |
Velan Capital Investment Management Lp |
10 Percent Owner |
1,188,500 |
2024-02-09 |
|
| 8 |
Carlyle Group Inc. |
Other: Former 10% Owner |
1,066,189 |
2024-02-12 |
|
| 9 |
Glazer Capital, Llc |
10 Percent Owner |
1,046,778 |
2021-04-23 |
|
| 10 |
Mahal Jeetinder Singh |
CEO and President |
500,000 |
2026-02-10 |
|
| 11 |
Martell Ron |
President, CEO and Director |
234,000 |
2026-01-05 |
|
| 12 |
Tucker Edwin Jonathan |
Chief Medical Officer |
90,000 |
2025-06-06 |
|
| 13 |
Cross Herb |
Chief Financial Officer |
90,000 |
2026-01-05 |
|
| 14 |
Abingworth Llp |
Director |
78,045 |
2022-03-23 |
|
| 15 |
Lis William |
Director |
53,521 |
2023-10-13 |
|
| 16 |
Klein Lawrence Otto |
Director |
47,000 |
2023-06-08 |
|
| 17 |
Shizuru Judith Anne |
Director |
41,000 |
2025-09-24 |
|
| 18 |
Wiggans Thomas G |
Director |
41,000 |
2025-09-24 |
|
| 19 |
Lucas Svetlana |
Director |
20,000 |
2025-09-24 |
|
| 20 |
Brun Scott C. |
Director |
7,500 |
2025-07-03 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-02-06 |
Mahal Jeetinder Singh |
CEO and President |
RSU Award |
500,000 |
$1.35 |
$675K |
| 2026-01-02 |
Mahal Jeetinder Singh |
Chief Operating Officer |
RSU Award |
90,000 |
$1.84 |
$165.6K |
| 2026-01-02 |
Cross Herb |
Chief Financial Officer |
RSU Award |
90,000 |
$1.84 |
$165.6K |
| 2026-01-02 |
Martell Ron |
President, CEO and Director |
RSU Award |
234,000 |
$1.84 |
$430.56K |
| 2025-09-22 |
Shizuru Judith Anne |
Director |
Informative Buy |
41,000 |
$2.92 |
$119.72K |
| 2025-09-22 |
Lucas Svetlana |
Director |
Informative Buy |
20,000 |
$2.92 |
$58.4K |
| 2025-09-22 |
Wiggans Thomas G |
Director |
Informative Buy |
41,000 |
$2.92 |
$119.72K |
| 2025-09-22 |
Martell Ron |
President and CEO |
Informative Buy |
41,000 |
$2.92 |
$119.72K |
| 2025-07-03 |
Shizuru Judith Anne |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-07-03 |
Brun Scott C. |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-07-03 |
Kapoor Vishal |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-07-03 |
Nolet Chris |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-07-03 |
Lucas Svetlana |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-07-03 |
Emster Kurt Von |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-07-03 |
Wiggans Thomas G |
Director |
RSU Award |
7,500 |
$6.77 |
$50.78K |
| 2025-06-04 |
Mahal Jeetinder Singh |
Chief Operating Officer |
RSU Award |
90,000 |
$6.00 |
$540K |
| 2025-06-04 |
Tucker Edwin Jonathan |
Chief Medical Officer |
RSU Award |
90,000 |
$6.00 |
$540K |
| 2025-06-04 |
Cross Herb |
Chief Financial Officer |
RSU Award |
90,000 |
$6.00 |
$540K |
| 2025-06-04 |
Martell Ron |
President and CEO |
RSU Award |
234,000 |
$6.00 |
$1.4M |
